Regulation of devices: a quickening pace

Area of Science:

• Medical device regulation
• Food and Drug Administration (FDA) policy
• Health technology assessment

Background:

• The Medical Device Amendments of 1976 represent a landmark regulatory framework.
• The Food and Drug Administration (FDA) was tasked with establishing specific regulatory components.
• The existing regulatory landscape shapes the trajectory of medical device innovation and oversight.

Purpose of the Study:

• To analyze the impact of the Medical Device Amendments of 1976 on FDA regulatory practices.
• To forecast the future climate for technological innovation in medical devices.
• To examine the implications of FDA's established procedures on regulatory actions and evidence handling.

Main Methods:

• Analysis of the Medical Device Amendments of 1976.
• Review of FDA's implementation of investigational device exemption regulations.
• Examination of FDA's recordkeeping requirements and informal hearing procedures.

Main Results:

• The FDA has successfully implemented key regulatory requirements, including investigational device exemptions, recordkeeping, and informal hearings.
• Technological innovation is anticipated to occur within a context of phased FDA involvement.
• Recordkeeping requirements are likely to be structured to enhance the FDA's capacity for regulatory enforcement.

Conclusions:

• The regulatory environment will foster innovation through incremental FDA engagement.
• Enhanced recordkeeping will empower the FDA to take more decisive regulatory actions.
• Informal hearings may be conducted by FDA employees with minimal evidentiary constraints, impacting regulatory decision-making.